| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |